Cerus Corp. (CERS)
2.655
-0.06
(-2.39%)
USD |
NASDAQ |
Aug 28, 16:00
2.655
0.00 (0.00%)
After-Hours: 18:13
Cerus Shareholders Equity (Quarterly) : 70.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.02M |
| March 31, 2026 | 67.55M |
| December 31, 2025 | 64.22M |
| September 30, 2025 | 61.46M |
| June 30, 2025 | 55.43M |
| March 31, 2025 | 55.49M |
| December 31, 2024 | 56.14M |
| September 30, 2024 | 53.49M |
| June 30, 2024 | 49.51M |
| March 31, 2024 | 49.37M |
| December 31, 2023 | 52.65M |
| September 30, 2023 | 48.17M |
| June 30, 2023 | 50.82M |
| March 31, 2023 | 58.63M |
| December 31, 2022 | 67.61M |
| September 30, 2022 | 73.12M |
| June 30, 2022 | 75.77M |
| March 31, 2022 | 79.41M |
| December 31, 2021 | 84.62M |
| September 30, 2021 | 80.08M |
| June 30, 2021 | 84.24M |
| March 31, 2021 | 92.64M |
| December 31, 2020 | 103.81M |
| September 30, 2020 | 109.24M |
| June 30, 2020 | 114.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 112.41M |
| December 31, 2019 | 57.05M |
| September 30, 2019 | 60.81M |
| June 30, 2019 | 65.63M |
| March 31, 2019 | 69.50M |
| December 31, 2018 | 84.52M |
| September 30, 2018 | 91.80M |
| June 30, 2018 | 90.44M |
| March 31, 2018 | 85.60M |
| December 31, 2017 | 38.94M |
| September 30, 2017 | 37.18M |
| June 30, 2017 | 39.29M |
| March 31, 2017 | 41.49M |
| December 31, 2016 | 57.79M |
| September 30, 2016 | 72.31M |
| June 30, 2016 | 74.64M |
| March 31, 2016 | 83.53M |
| December 31, 2015 | 94.76M |
| September 30, 2015 | 95.52M |
| June 30, 2015 | 110.53M |
| March 31, 2015 | 109.94M |
| December 31, 2014 | 41.52M |
| September 30, 2014 | 47.28M |
| June 30, 2014 | 44.21M |
| March 31, 2014 | 44.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DexCom, Inc. | 2.621B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.19M |
| Total Liabilities (Quarterly) | 134.47M |
| Debt to Equity Ratio | 1.097 |
| Current Ratio | 1.834 |
| Net Debt Paydown Yield | 0.77% |